Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-08-26 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
北京炜衡（宁波）律师事务所关于宁波新芝生物科技股份有限公司2024年第二次临时股东大会的法律意见书
Regulatory Filings Classification · 75% confidence The document is a legal opinion letter issued by a law firm concerning the convening, procedures, attendance qualifications, and voting validity/results of Ningbo Xinzhi Biotechnology’s 2024 second extraordinary general meeting (EGM). It is neither the notice of meeting materials (AGM/EGM information) nor a simple vote results announcement (DVA), but rather a specialized legal opinion as part of the company’s disclosure. It does not fit any other narrowly defined category, so it falls under the miscellaneous regulatory filings bucket (RNS).
2024-08-26 Chinese
2024年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2024 second extraordinary shareholders meeting of Ningbo New Zhisheng Biotechnology Co., Ltd. It details the meeting date, attendance, voting results, and the appointment of a new director. It includes legal opinions confirming the validity of the meeting and resolutions. There are no financial statements or detailed financial data presented. The document is primarily about board/management changes and the official voting results of the shareholders meeting. Given the focus on the appointment of a new director and the voting results, the document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and it is not a full report but an announcement of meeting resolutions and voting outcomes.
2024-08-26 Chinese
2024年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2024 年半年度报告" which translates to "2024 Semi-Annual Report" or "Interim Report". It contains detailed financial data such as revenue, profit, asset and liability figures, and operational data for the period January 1, 2024 to June 30, 2024. The document includes sections on accounting data, business overview, industry analysis, and risk factors. It explicitly states the report period as the first half of 2024 and includes comprehensive financial statements and management discussion. The length of the document (15,000 characters) and the detailed financial and operational content confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-26 Chinese
2024年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集资金存放与实际使用情况的专项报告" which translates to a "Special Report on the Deposit and Actual Use of Raised Funds." It details the amount of funds raised, their usage, management, and balance as of June 30, 2024. It includes detailed financial tables about the raised funds, their allocation to projects, and cash management activities. The document references approvals from the board and shareholders, and includes audit verification reports from an accounting firm. The content focuses on the use and management of capital raised through stock issuance, including compliance with regulatory requirements and investment of idle funds. This is a detailed report on capital raising and usage, not a general annual or interim financial report, nor an announcement or certification. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (8317 characters) and detailed financial data support this classification with high confidence.
2024-08-26 Chinese
会计政策变更公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policies by the company Ningbo New Zhi Biotechnology Co., Ltd. It details the nature of the accounting policy change, the reasons for the change, and the approvals by the board, supervisory board, and audit committee. It does not contain actual financial statements or detailed financial data but rather informs stakeholders about the policy change and its expected impact. The document is relatively short (1710 characters) and serves as a formal announcement rather than a full financial report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-26 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '半年度报告摘要' which translates to 'Half-Year Report Summary' for 2024. It contains detailed financial data for the half-year period, including assets, liabilities, net profit, earnings per share, and other financial metrics. It also includes company business descriptions, shareholder information, and management assurances about the report's accuracy. The length is over 6,000 characters and the content includes substantive financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, and it is not a full annual report (10-K). Therefore, the correct classification is IR with high confidence. H1 2024
2024-08-26 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.